Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $59.9 million.

  • Medifast's Operating Expenses fell 3150.15% to $59.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $289.4 million, marking a year-over-year decrease of 3448.69%. This contributed to the annual value of $289.4 million for FY2025, which is 3448.71% down from last year.
  • Per Medifast's latest filing, its Operating Expenses stood at $59.9 million for Q4 2025, which was down 3150.15% from $66.2 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Operating Expenses ranged from a high of $272.7 million in Q2 2022 and a low of $59.9 million during Q4 2025
  • In the last 5 years, Medifast's Operating Expenses had a median value of $161.9 million in 2023 and averaged $162.4 million.
  • As far as peak fluctuations go, Medifast's Operating Expenses soared by 7703.6% in 2021, and later crashed by 4082.12% in 2025.
  • Medifast's Operating Expenses (Quarter) stood at $231.4 million in 2021, then dropped by 13.16% to $201.0 million in 2022, then crashed by 33.98% to $132.7 million in 2023, then crashed by 34.05% to $87.5 million in 2024, then crashed by 31.5% to $59.9 million in 2025.
  • Its last three reported values are $59.9 million in Q4 2025, $66.2 million for Q3 2025, and $77.7 million during Q2 2025.